Neurologists at the University of Chicago Medicine Multiple Sclerosis Clinic are dedicated to improving the quality of life for people with multiple sclerosis (MS). We have a distinguished record of providing definitive diagnoses and comprehensive treatments to help patients manage their symptoms and limit flare-ups. Our multidisciplinary team collaborates to determine the best treatment for each individual patient.
Multiple sclerosis is a chronic, autoimmune disease of the central nervous system. While the exact cause is not known, scientists do know that MS causes a person's white blood cells to attack their myelin (a fatty substance that insulates nerve fibers), damaging the nerve impulses that travel to and from the brain and spinal cord. Symptoms — often unpredictable and erratic — range from mild to severe and vary by patient.

Some common symptoms may include:
  • Blurred vision 
  • Fatigue
  • Numbness
  • Progressive leg weakness
  • Problems with bowel, bladder and sexual function
  • Trigeminal neuralgia, a condition that causes sudden, severe facial pain
  • Spastic movements
Due to the complex and varying nature of MS, experience in treating and researching the disease is a key to determining the best treatments. Neurologists at UChicago Medicine have a long history of expert clinical care and research in multiple sclerosis. The physicians who treat multiple sclerosis patients are the same ones who research the causes and mechanisms of MS, develop effective treatments for the disease and proactively search for a cure.
Neurologists at UChicago Medicine are always studying new ways to diagnose and treat multiple sclerosis, and have consistently been at the forefront of advancements in autoimmune diseases. In 1993, our researchers helped develop and test interferon, the first FDA-approved treatment for multiple sclerosis. This "disease-modifying" therapy reduces exacerbations, improves function and memory and lowers death rates. In the past two decades, several new medications have been approved for new and relapsing disease. In addition to offering these therapies, our neurologists are directly involved in ongoing clinical trials to determine the effectiveness of the next generation of multiple sclerosis medications and diagnostic tools.

Translating MS Research from 'Bench to Bedside'

Our specialists are dedicated to translating biomedical discoveries from laboratory findings to innovative therapies. Because the physicians at the UChicago Medicine Multiple Sclerosis Clinic are the same research scientists leading the search for a cure, they bring a unique understanding of complex treatments to patient care. In addition to having access to the latest medications, they understand which treatment option is best for each course of MS and, through a personalized approach to care, can identify the best therapy for each patient.